Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C: Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1
Budget-constrained individuals: If cost is a major concern, focus resources on diet, exercise, and possibly oral supplements first
"This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease," said study lead author Dr
Emerging research directions are exploring novel applications of NAD+ biology in areas such as cancer metabolism, immune function, and regenerative medicine
Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential
Walton RG, Dungan CM, Long DE, et al